Brief: Precipio And H3 Biomedicine Sign Second Development Agreement

Precipio

25/06/2019 14:36

June 25 (Reuters) - Precipio Inc  PRPO.O :
    * PRECIPIO AND H3 BIOMEDICINE SIGN SECOND DEVELOPMENT
AGREEMENT
    * PRECIPIO - SECOND DEVELOPMENT PROJECT BETWEEN COMPANIES
WILL
FOCUS ON DEVELOPMENT OF MULTIPLEXED PCR ASSAYS FOR FGFR3,
PIK3CA, HRAS, TERT AND PLEKHS1
    * PRECIPIO INC - PANEL WOULD BE USED BY H3 BIOMEDICINE FOR
THEIR
ONGOING CLINICAL DEVELOPMENT PROGRAMS.

Source text for Eikon:  ID:nGNX3M9S5S 
Further company coverage:  PRPO.O 

 (((Reuters.Briefs@thomsonreuters.com);;))